Index of reports
> Cases with Mucous Membrane Disorder (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mustargen (Mechlorethamine) where reactions include mucous membrane disorder. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mustargen side effects in 40 year old male
Reported by a physician from Japan on 2011-10-06
Patient: 40 year old male
Reactions: Renal Disorder, Bone Marrow Failure, Mucous Membrane Disorder
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Hodgkin's Disease
Adriamycin PFS
Indication: Immunodeficiency
Adriamycin PFS
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Cyclosporine
Indication: Immunodeficiency
Cyclosporine
Indication: Hodgkin's Disease
Etoposide
Indication: Immunodeficiency
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Hodgkin's Disease
Methotrexate
Indication: Hodgkin's Disease
Methotrexate Sodium
Indication: Immunodeficiency
Methotrexate Sodium
Indication: Diffuse Large B-Cell Lymphoma
Mustargen
Indication: Diffuse Large B-Cell Lymphoma
Mustargen
Indication: Hodgkin's Disease
Mustargen
Indication: Immunodeficiency
Oncovin
Indication: Diffuse Large B-Cell Lymphoma
Oncovin
Indication: Immunodeficiency
Oncovin
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Prednisone
Indication: Immunodeficiency
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Procarbazine Hydrochloride
Indication: Immunodeficiency
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
|